Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Drug and Biotech Stocks

Pharmaceutical stocks performed less poorly than did biotechs

by WILLIAM J. STORCK, C&EN NORTHEAST NEWS BUREAU
October 11, 2004 | A version of this story appeared in Volume 82, Issue 41

MORE ON THIS STORY
CHEMICAL STOCKS
Growth in chemical company share prices continued to beat the Dow Jones in the third quarter
Table 1 - Chemical Stocks Continue To Rise
C&EN's biotech index falls, while the drug index is battered by plunge in Merck's stock price
Table 2 - Drug And Biotech Stocks
Pharmaceutical stocks performed less poorly than did biotechs

 

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.